Aim: The appropriate additional surgery after non-curative resection of Endoscopic Mucosal
Resection (ESD) for early gastric cancer is herein discussed. Patients and Methods: Data on …

Abstract Purpose In Japan, the majority of early gastric cancers (EGCs) are now treated with
endoscopic submucosal dissection (ESD). Patients with non-curative lesions treated by ESD …

Background Limited surgery by endoscopic mucosal resection (EMR) or endoscopic
submucosal dissection (ESD) for gastric cancer is frequently performed in many institutions …

Background Endoscopic resection is widely accepted as the primary treatment for early
gastric cancer (EGC) without lymph node metastasis. A new and refined technique …

Purpose Endoscopic mucosal resection (EMR) is a relatively new treatment option for early
gastric cancer (EGC). However, cases of incomplete EMR resulting in a positive lateral …

The aim of this study was to examine the clinicopathological characteristics of cases
undergoing additional gastrectomy after endoscopic mucosal resection (EMR) for early …

Background Although the number of patients with early gastric cancer (EGC) treated by
endoscopic mucosal resection (EMR) has increased, the appropriate strategy for treating …

Background: Endoscopic submucosal dissection (ESD) was developed to resect early
gastric cancer (EGC), which could not be resected by conventional endoscopic mucosal …

Endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) is an
effective alternative treatment for early gastric cancer. However, a major concern is the …

Results: En bloc and complete resection rates were 96.7% and 91.7%, respectively. During
a median follow-up of 36 months (range 2–93 months), two local recurrences occurred …